News | Artificial Intelligence | February 08, 2024

Paige, a global provider of end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications that assist in diagnosing cancer, has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers.

Paige deepens its AppLab's offerings by partnering with industry-leading third-party AI providers

Paige, a global provider of end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications that assist in diagnosing cancer, has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. Image courtesy: Paige.AI


February 8, 2024 — Paige, a global leader in end-to-end digital pathology solutions and clinical Artificial Intelligence (AI) applications that assist in diagnosing cancer, today announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. New applications from these industry-leading companies, including ImageneHistofyAiosynClinsightDoMore Diagnostics, and Stratipath*, will be added to the AppLab to provide support for pathology labs worldwide in building deeply integrated and customized AI-enabled workflows. 

The Paige AppLab is a comprehensive marketplace where, within a few clicks, pathologists can seamlessly browse, trial, and purchase a robust set of diagnostic support tools from various providers that can be then accessed in the Paige Platform and FullFocus viewer to support each unique step of cancer diagnosis.  The AppLab delivers full vendor-neutrality and flexibility to ensure labs are equipped with all the insights they need—from Paige or other partners—to efficiently meet the unique needs of their patients, now and in the future.  

The newly introduced applications unlock advanced AI-powered capabilities such as biomarker detection from H&E-stained slides, assistance with the grading and assessment of cancer across tissue types, risk-stratification, and more. Paige has worked closely with each AppLab vendor to ensure their technology is seamlessly integrated into the Paige Platform to simplify AI adoption and propel the practice of digital pathology forward.  

“We are excited to be part of Paige’s AppLab which ensures seamless and easy integration of AI solutions for end users. This is critical to bring innovation in the field forward,” said Torbjørn Furuseth, MD, Co-Founder and CEO of DoMore Diagnostics. “Paige will be a key partner as we continue to push the boundaries to personalize cancer treatment with our Histotype Px digital biomarkers.”  

Nasir Rajpoot, PhD, Co-Founder and Chief Scientific Officer of Histofy, added, "Paige AppLab allows Histofy a very exciting route for putting our groundbreaking AI solutions in the hands of a rapidly increasing number of pathologists and researchers using the Paige Platform. We are excited at the prospect of delivering our AI tools to market through Paige." 

Designed for real-world clinical utilization, Paige is committed to arming pathologists with the highest-quality products. Each new application can be trusted to work alongside Paige tools and applications to offer one powerful guidance engine that truly unlocks the full potential of digital pathology and AI. 

“We are excited to welcome these six additional industry-leading digital pathology vendors to the Paige AppLab. Their partnership serves as a testament to the innovative and cutting-edge technology Paige is built upon,” said Jill Sue, Vice President of Product, Paige. “With these vendor additions, the Paige AppLab serves as the one-stop-shop for all digital pathology needs.”  

*Stratipath breast is CE-IVD marked for clinical use 

For more information: https://paige.ai/


Related Content

News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Information Technology

June 21, 2024 — Konica Minolta Healthcare Americas announced today a strategic partnership with Comp-Ray, Inc., a ...

Time June 21, 2024
arrow
News | Enterprise Imaging

June 20, 2024 — Agfa announces its participation in the upcoming Society for Imaging Informatics in Medicine (SIIM) 2024 ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Cybersecurity

June 19, 2024 —Karamba Security, a world leader in end-to-end product security, today announced the signing of a ...

Time June 19, 2024
arrow
News | Breast Imaging

June 18, 2024 — Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue Breast ...

Time June 18, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
Feature | Imaging Technology News - ITN

Dear Friends and Readers of ITN, Can you spare 3 minutes today to give us some feedback? Please share your insight with ...

Time June 17, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PACS

June 13, 2024 — Cloud-PACS radiology solutions provider SynthesisHealth, Inc. has signed three new contracts with ...

Time June 13, 2024
arrow
Subscribe Now